Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency
Clinical trial NCT03288103 · COMPLETED
Trial details
- NCT number
- NCT03288103
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-01
- Primary completion
- 2023-03-31
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.